1. Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling
    Sergei Spitsin et al, 2018, J Leukoc Biol CrossRef
  2. null
    Michael Berger et al, 2018 CrossRef
  3. MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα
    Xiaobin Liu et al, 2018, Life Sciences CrossRef
  4. null
    Michael Berger et al, 2019 CrossRef
  5. null
    Michael Berger et al, 2019 CrossRef
  6. Neurokinin-1 Receptor Antagonists against Hepatoblastoma
    Miguel Muñoz et al, 2019, Cancers CrossRef
  7. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
    Chentao Ge et al, 2019, Proc Natl Acad Sci U S A CrossRef
  8. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata
    Ayoze González-Santana et al, 2016, Fertility and Sterility CrossRef
  9. The Role of Tachykinins in the Initiation and Progression of Gastrointestinal Cancers: A Review
    Pedram Hashemian et al, 2020, Int J Cancer Manag CrossRef
  10. null
    Matthias Ilmer et al, 2020 CrossRef
  11. Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer
    Iris Beirith et al, 2021, Cancers CrossRef
  12. N-acetyl-L-tryptophan attenuates hepatic ischemia-reperfusion injury via regulating TLR4/NLRP3 signaling pathway in rats
    Yitong Pan et al, 2021 CrossRef
  13. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors
    Julian Kolorz et al, 2021, Current Oncology CrossRef
  14. Effects of substance P on human cerebral microvascular endothelial cell line hCMEC/D3 are mediated exclusively through a truncated NK-1 receptor and depend on cell confluence
    Xin Gao et al, 2022, Neuropeptides CrossRef
  15. The Neurokinin-1 Receptor: A Promising Antitumor Target
    Rafael Coveñas et al, 2022, Receptors CrossRef
  16. null
    Rafael Coveñas et al, 2024 CrossRef